Tipiracil NEW
| Price | $30 |
| Package | 2mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Tipiracil | CAS No.: 183204-74-2 |
| Purity: 99.81% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Tipiracil |
| Description | Tipiracil is a pharmacological agent that inhibits the enzyme thymidine phosphorylase. Tipiracil is under research for combination effect with trifluridine in advanced or metastatic colorectal and gastric cancers. By inhibiting thymidine phosphorylase, Tipiracil enhances the bioavailability and efficacy of trifluridine, offering alternative in cancer research. |
| In vitro | Tipiracil functions as a thymidine phosphorylase inhibitor, enhancing trifluridine's efficacy by impeding its metabolism via thymidine phosphorylase. This synergistic action facilitates the use of the Trifluridine-Tipiracil combination as an innovative oral treatment for metastatic colorectal cancer [2]. Additionally, Tipiracil fortifies the stability of FTD by mitigating its first-pass degradation through its inhibitory action on thymidine phosphorylase [3]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 0.8 mg/mL (3.3 mM), Sonication is recommended. DMSO : < 1 mg/mL (insoluble) |
| Inhibitors Related | Stavudine | 5-Fluorouracil | Adenine hemisulfate | Erythromycin thiocyanate | Uridine | Guanidine hydrochloride | Hexane-1,6-diol | 1,4-Naphthoquinone | Adenine | Carbazole | Thymidine | Usnic Acid |
| Related Compound Libraries | DNA Damage & Repair Compound Library | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Approved Drug Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | NMPA-Approved Drug Library | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $43.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-26 | |
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-06-05 | ||
|
Moxin Chemicals
|
2025-12-16 | |||
| $1.00 |
VIP6Y
|
Career Henan Chemica Co
|
2024-10-22 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY